PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease ReportsMajor depressive disorder
MeSH D003865 - major depressive disorder
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D003866:Depressive disorder
$
Success rate
D003865: 
Major depressive disorder
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaBrexpiprazole Brexpiprazole  2022-08-11   
Desvenlafaxine Desvenlafaxine  2013-10-11   
Duloxetine Duloxetine  2013-12-11   
Escitalopram oxalate Escitalopram Oxalate  2012-03-14   
Fluoxetine Fluoxetine  2002-01-31   
Lurasidone Lurasidone  2019-05-17   
Olanzapine, Fluoxetine Olanzapine Fluoxetine  2012-06-19   
Quetiapine Quetiapine  2012-03-27   
Fluoxetine Selfemra  2014-02-03   
Vilazodone Vilazodone  2019-09-30   
Novast LaboratoriesQuetiapine Quetiapine  2017-11-29   
Taro PharmaceuticalEscitalopram oxalate Escitalopram Oxalate  2012-05-03   
Appco PharmaFluoxetine Fluoxetine  2018-11-21   
MylanDesvenlafaxine Desvenlafaxine  2015-06-29   
Duloxetine Duloxetine Mylan  2015-06-19   
Fluoxetine hydrochloride Fluoxetine  2002-01-30   
Quetiapine Quetiapine  2012-03-27   
Rising PharmaceuticalsEscitalopram oxalate Escitalopram Oxalate  2007-07-31   
Quetiapine Quetiapine  2012-03-27   
Fluoxetine Fluoxetine  2001-08-02   
NATCO PharmaFluoxetine Fluoxetine  2008-11-17   
CiplaEscitalopram oxalate Escitalopram Oxalate  2012-09-11   
Lurasidone Lurasidone  2019-01-03   
Vilazodone Vilazodone  2021-04-07   
Lupin ResearchDesvenlafaxine Desvenlafaxine  2015-06-29   
Duloxetine Duloxetine  2013-12-11   
Fluoxetine Fluoxetine  2019-02-08   
Lurasidone Lurasidone  2019-01-03   
Quetiapine Quetiapine  2012-03-27   
Brexpiprazole Brexpiprazole  2023-03-17   
Chartwell PharmaceuticalsEscitalopram oxalate Escitalopram Oxalate  2012-09-11   
Quetiapine Quetiapine  2012-12-14   
Fluoxetine Fluoxetine  2008-01-16   
Lurasidone Lurasidone  2020-12-28   
Brexpiprazole Brexpiprazole  2023-10-25   
1
2
3
4
5
6
...
8
>
Clinical Trials
Historical Success Rate
Phase 1
72%
65/90
Phase 2
60%
76/127
Phase 3
56%
54/96
Approved: 14Overall Success rate: 24%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
Mylan
1
2
3
4
5
6
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use